Eleven Biotherapeutics Announces Effectiveness of Investigational New Drug Application for EBI-031

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Eleven Biotherapeutics announces IND effectiveness for EBI-031 triggering $22.5 million milestone payment from Roche